William Blair & Company’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69.3K Buy
+30,400
New +$88.3K ﹤0.01% 1651
2025
Q2
Sell
-20,300
Closed -$85.1K 1882
2025
Q1
$85.1K Hold
20,300
﹤0.01% 1522
2024
Q4
$97.8K Buy
20,300
+9,900
+95% +$46.4K ﹤0.01% 1529
2024
Q3
$38.3K Buy
+10,400
New +$36.8K ﹤0.01% 1660
2021
Q4
Sell
-25,129
Closed -$675K 2010
2021
Q3
$675K Buy
+25,129
New +$724K ﹤0.01% 1055
2019
Q2
Sell
-11,145
Closed -$254K 1760
2019
Q1
$254K Buy
11,145
+204
+2% +$4.6K ﹤0.01% 1210
2018
Q4
$254K Buy
+10,941
New +$292K ﹤0.01% 1143

Other funds holding PETS

William Blair & Company's PETS Position: Q1 2026 in Review

William Blair & Company opened a new position in PetMed Express (PETS) in Q1 2026: 30,400 shares worth $69.3K. The stake represents ﹤0.01% of the portfolio and ranks #1651 among its holdings. This is a return to the name: William Blair & Company previously reported a position in PETS as recently as Q1 2025.

William Blair & Company first reported a position in PETS in Q4 2018 and has held it in 7 quarters since. The position peaked at $675K in Q3 2021. 49 funds tracked by Wall St. Rank hold PETS as of Q1 2026.

  • William Blair & Company held 30,400 shares of PetMed Express worth $69.3K as of Q1 2026.
  • PetMed Express was a new William Blair & Company position in Q1 2026.
  • PetMed Express made up ﹤0.01% of William Blair & Company's portfolio in Q1 2026, its #1651 holding.
  • William Blair & Company first reported a position in PetMed Express in Q4 2018 and has held it in 7 quarters since.
  • William Blair & Company's PetMed Express position peaked at $675K in Q3 2021.
  • 49 funds tracked by Wall St. Rank held PetMed Express as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.